Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Anaphylaxis is an acute, life-threatening allergic emergency. Numerous studies have highlighted shortcomings in the emergency management of anaphylaxis, which is of considerable concern as sub-optimal immediate management increases the risk of poor outcomes. Death typically results from compromise of the cardiovascular and/or respiratory system and so emergency treatment should aim to restore blood pressure and relieve respiratory obstruction. This article provides insights on the recognition of anaphylaxis, summarises key clinically relevant insights from epidemiological investigations, and provides a state-of-the-art synopsis on the evidence-based emergency management of anaphylaxis.

Original publication

DOI

10.1517/14656566.2013.781583

Type

Journal article

Journal

Expert opinion on pharmacotherapy

Publication Date

05/2013

Volume

14

Pages

827 - 830

Keywords

Humans, Anaphylaxis, Epinephrine, Adrenal Cortex Hormones, Adrenergic Agonists, Histamine Antagonists, Emergency Treatment